Biden budget proposes increased funding for ending HIV

As the world marks the 40th anniversary of the CDC’s first reporting on what we now know to be AIDS, President Joe Biden is proposing in his budget released Friday to continue to ramp up efforts to finally end HIV in the United States. In addition to the increase of $267 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic initiative, which was announced as part of the preliminary budget, Biden is proposing a $46 million increase to the Ryan White HIV/AIDS Programs and $20 million for HUD’s Housing Opportunities for Persons with AIDS (HOPWA) program.

124 patient groups urge Biden administration to improve prescription drug affordability

WASHINGTON, DC… The HIV+Hepatitis Policy Institute (HIV+Hep) and American Autoimmune Related Diseases Association (AARDA), in collaboration with 122 other patient and provider organizations, delivered a sign-on letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra that urges HHS and the Biden administration to enact policies and protections that improve prescription drug affordability for the American people.

HIV+Hep welcomes first Hepatitis strategic plan that calls for elimination

Washington DC… The HIV+Hepatitis Policy Institute applauds the U.S. Department of Health and Human Services (HHS) for today’s release of Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021 – 2025)…

Enforcement Needed to Ensure Health-Plan Compliance With HIV Preventive Drug Requirement

As we begin 2021, almost everyone with private health insurance will have free access to drugs that prevent HIV infection, known as pre-exposure prophylaxis, or PrEP. To start with, it is remarkable that such medications exist, and so important that health care coverage laws emphasize preventive services.

HIV+Hep welcomes release of HIV national strategic plan

Washington DC… The HIV+Hepatitis Policy Institute applauds the release of the HIV National Strategic Plan: A Roadmap to End the Epidemic by the U.S. Department of Health and Human Services…

Biden administration pulls last-minute Trump Medicare drug demo plan

Washington DC… In a victory for patients who depend on Medicare Part D for their medications, the Biden administration has pulled a demonstration project that would have allowed participating Medicare plans in 2022 to not cover all drugs in certain classes and only one drug per class in all others. The proposal that was pulled was announced literally in the final hours of the Trump administration.

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Causes We Care About, and So Should You!

HIV

Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

3 hours ago
. @SpeakerCupp - Here’s why we need #OhioHB135! #PatientsCantWait #AllCopaysCount @DarrelRowland
Health insurance co-pay accumulators little known, costly for patients https://t.co/kaUR9oqQpp
6 hours ago
Mississippi becomes the first state to jointly sue drug makers and PBMs over the cost of insulin https://t.co/Ud3lmOjUJE via @statnews
6 hours ago
$1.5 trillion spending cap tucked into House rule for vote Monday night https://t.co/TIvQ2PoEX8
6 hours ago
@HIVHep & @AARDATweets, in collaboration w/ 122 other patient organizations, delivered a letter ( https://t.co/TsIPR1kf45) to @SecBecerra that urges @HHSGov & the @JoeBiden admin. to enact policies & protections that improve #Rx affordability: https://t.co/bJ3v1E4mig
8 hours ago
@HIVHep Exec Dir Carl Schmid writes: "Health insurers must do their part by making sure they offer #PrEP without cost-sharing, and government regulators must hold insurers accountable." Read more on why the @JoeBiden admin should prioritize enforcement: https://t.co/UyUh1jsUPz https://t.co/mqZjZhg5Bs HIVHep photo
10 hours ago
@HIVHep’s Carl Schmid & @orasure’s Giffin Daughtridge on #hepC testing: “We need to ⬆️ access & availability to key diagnostic technologies, particularly in outreach & high prevalence settings, such as correctional facilities & syringe services programs”: https://t.co/MioCuhAkDD

Pin It on Pinterest